Jump to content

COVID 19 coverup


Recommended Posts

KEY DATES IN COVID COVER-UP

November 9, 2015:

Wuhan Institute of Virology publish a study revealing they created a new virus in the lab from SARS-CoV.

December 6, 2019

Five days after a man linked to Wuhan’s seafood market presented pneumonia-like symptoms, his wife contracts it, suggesting human to human transmission.

December 27

China’s health authorities told a novel disease, then affecting some 180 patients, was caused by a new coronavirus.

December 26-30

Evidence of new virus emerges from Wuhan patient data.

December 31

Chinese internet authorities begin censoring terms from social media such as Wuhan Unknown Pneumonia.

January 1, 2020

Eight Wuhan doctors who warned about new virus are detained and condemned.

January 3

China’s top health authority issues a gag order.

January 5

Wuhan Municipal Health Commission stops releasing daily updates on new cases. Continues until January 18.

January 10

PRC official Wang Guangfa says outbreak “under control” and mostly a “mild condition”.

January 12

Professor Zhang Yongzhen’s lab in Shanghai is closed by authorities for “rectification”, one day after it shares genomic sequence data with the world for the first time.

January 14

PRC National Health Commission chief Ma Xiaowei privately warns colleagues the virus is likely to develop into a major public health event.

January 24

Officials in Beijing prevent the Wuhan Institute of Virology from sharing sample isolates with the University of Texas.

February 6

China’s internet watchdog tightens controls on social media platforms.

February 9

Citizen-journalist and local businessman Fang Bin disappears.

April 17

Wuhan belatedly raises its official fatalities by 1290.

 

https://www.dailytelegraph.com.au/coronavirus/bombshell-dossier-lays-out-case-against-chinese-bat-virus-program/news-story/55add857058731c9c71c0e96ad17da60

Link to comment
Share on other sites

THE LAB WORKER WHO DISAPPEARED

Out of all the doctors, activists, journalists and scientists who have reportedly disappeared after speaking out about the coronavirus or criticising the response of Chinese authorities, no case is more intriguing and worrying than that of Huang Yan Ling.

A researcher at the Wuhan Institute of Virology, the South China Morning Post reported rumours swirling on Chinese social media that she was the first to be diagnosed with the disease and was ­“patient zero”.

Then came her reported disappearance, with her biography and image deleted from the Wuhan Institute of Virology’s website.

On February 16 the institute denied she was ­patient zero and said she was alive and well, but there has been no proof of life since then, fanning speculation.

Link to comment
Share on other sites

Engineered bat virus stirs debate over risky research 

Lab-made coronavirus related to SARS can infect human cells.

Editors’ note, March 2020: We are aware that this story is being used as the basis for unverified theories that the novel coronavirus causing COVID-19 was engineered. There is no evidence that this is true; scientists believe that an animal is the most likely source of the coronavirus.

https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-1.18787

This article in 2015 was published in Nature medicine journal but now editor put a note that bat is the most likely source of virus. Scientists all over the world believe that virus is natural. 

Link to comment
Share on other sites

It does not matter whether it's created in lab or spread from animals to humans, but Chinese should be made responsible for this pandemic. They should have blocked their nationals from travelling to other countries and must have informed the world about it. 

WHO also miserably failed

Link to comment
Share on other sites

1 hour ago, uppalapati123 said:

It does not matter whether it's created in lab or spread from animals to humans, but Chinese should be made responsible for this pandemic. They should have blocked their nationals from travelling to other countries and must have informed the world about it. 

WHO also miserably failed

WHO is the main culprit

Link to comment
Share on other sites

  • 3 weeks later...

Tensions surrounding the global handling of the coronavirus pandemic came to a head at the World Health Organization's assembly Monday, with China pledging an extra $2 billion to deal with the crisis and the United States blaming the WHO for a failed response that "cost many lives."

Link to comment
Share on other sites

Oxford COVID-19 vaccine to begin phase II/III human trials
 

The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing.

The next study will enrol up to 10,260 adults and children and will involve a number of partner institutions across the country.

The phase II part of the study involves expanding the age range of people the vaccine is assessed in, to include a small number of older adults and children:

• Aged 56-69
• Aged over 70
• Aged between 5-12 years

For these groups, researchers will be assessing the immune response to the vaccine in people of different ages, to find out if there is variation in how well the immune system responds in older people or children.

The phase III part of the study involves assessing how the vaccine works in a large number of people over the age of 18. This group will assess how well the vaccine works to prevent people from becoming infected and unwell with COVID-19.

Adult participants in both the Phase II and Phase III groups will be randomised to receive one or two doses of either the ChAdOx1 nCoV-19 vaccine or a licensed vaccine (MenACWY) that will be used as a ‘control’ for comparison.

ChAdOx1 nCoV-19 is made from a virus (ChAdOx1), which is a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees, that has been genetically changed so that it is impossible for it to replicate in humans.


 

Who can take part in the study?

Participants must:

Participants must NOT:

Be in one of the relevant age categories

Have tested positive for COVID-19

Be in good health

Be pregnant, intending to become pregnant, or breastfeeding during the study

Based in one of the recruiting areas

Have previously taken part in a trial with an adenoviral vaccine or received any other coronavirus vaccines

 Full inclusion and exclusion criteria is available in the participant information sheet.

How will the trial work?

The main focus of the study is to find out if this vaccine is going to work against COVID-19, if it won’t cause unacceptable side effects and if it induces good immune responses. The dose used in this trial was chosen based on previous experiences with other ChAdOx1 based vaccines.

Study participants will not know whether they have received the ChAdOx1 nCoV-19 vaccine until the end of the trial.

To recruit the large number of participants needed for this trial, multiple clinical research sites across the UK are involved in delivering the study. This is a collaborative effort led by the University of Oxford and a full list of our study sites is available on our website. Vaccinations will be taking place across the sites in May and June.

What about after the vaccination?

Some participants will be given an E-diary to record any symptoms experienced for 7 days after receiving the vaccine and if they feel unwell for the following 3 weeks. There is also a weekly survey that participants will be asked to complete about any household exposure to COVID-19.

In order to monitor exposure to COVID-19 in people who do not have symptoms, participants in some areas will be asked to collect swabs at home to be sent to the laboratory for testing.

Following vaccination, participants will attend a series of short follow-up visits. During these visits, the team will check participants’ observations, take a blood sample and review the completed E-diary and questionnaire. These blood samples will be used to assess the immune response to the vaccine.

If participants develop COVID-19 symptoms during the study, they can contact a member of the clinical team, and we will assess them to check whether they have become infected with the virus. If a participant was very unwell, we would call our colleagues in the hospital and ask them to review the volunteer if appropriate.

What if it doesn’t work?

A significant proportion of vaccines that are tested in clinical trials don’t work. If we are unable to show that the vaccine is protective against the virus, we would review progress, examine alternative approaches, such as using different numbers of doses, and would potentially stop the programme.

http://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trials#

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...